top of page
Blue Skies

The Plasmonic Imaging Company

 

â„ 

unlocking cell to cell messaging

The future of live cell imaging.

Know your cells better; cost-competitive with no capital expense.

Scroll Down

About Us

Based in Frederick, Maryland, Nanocrine is pioneering the commercial availability of nanoplasmonic biosensors for everyday use in leading cell biology laboratories. We design our biosensors as single use biochips that work with standard live cell  microscopes and require no new instrumentation – simply open the packages, gather data, and achieve breakthrough results at affordable prices.

​

Nanocrine plasmonic biosensors are being developed to image the protein secretions of live cells in real time. Our goal is to empower researchers with the capacity to obtain advanced understanding of their cells' behaviors, enhancing the precision and reproducibility of their live cell imaging experiments.

  • Our cell surface chemistry expertise improves live cell phenotyping and reproducibility.

  • Our Contact Guidance surfaces provide atomically smooth features with precise channel depths that improve the precision of cell behavior studies.

  • Our nanoplasmonic biosensors are being applied to elucidate cell messaging relevant to stem cell research, neurodegenerative and cardiovascular disease, and oncology.

Male Scientist
Image by Catherine Avak

Order Contact Guidance Chips

Dotted-PNG-File.png
Investors
Laboratory
Science Class
222.png

The Plasmonic Imaging Company

Unlocking Cell-to-Cell Messaging

Interested parties, please contact Investor Relations to request further information, including access to the Data Room or to set up a meeting.

​

InvestorRelations@nanocrine.com;

+1.240.439.6340 

bg1.png
Team

Management

1.png

Patrick Calhoun, Ph.D.

​

President & Chief Science Officer

Cell Biologist/Virologist with focus in cellular communication, intracellular signaling

Patrick received his PhD from Virginia Tech followed by postdoctoral training at Johns Hopkins School of Medicine. His scientific interests include intercellular communication, intracellular signaling pathways, and viral pathogenesis. He joined Nanocrine to lead cell biology advancements and product development, including a platform for label-free phenotype-based assays for determination of viral infection.

Screenshot 2024-10-29 at 02.14.42.png
2.png

Steve Turner

​

Co-Founder, Chairman

Life Sciences Business Development

Steve has a forty-year career serving as founder and executive of life science companies, including the BRL Division of Life Technologies, Oncor, OncorMed, and Quorum Sciences. He focuses on commercializing new life science technology platforms and served as Director of Marketing for the Microbiology Division of Becton, Dickinson & Co. He is a graduate of Stanford University.

3.png

Marc Raphael, Ph.D.

​

Advisor, Technology Inventor

Biophysics Laboratory Director,

U.S. Naval Research Laboratory

Marc received his PhD in physics from Catholic University and leads an interdisciplinary team of physicists, material scientists, and bioengineers at the United States Naval Research Laboratory in Washington, D.C.

He is the inventor of the technology used in the Nanocrine Plasmonic Chip.

Screenshot_2024-10-30_at_11.48.37-removebg-preview.png
Custom Services
  • Custom in vitro surfaces functionalized with the peptide or protein of your choice.

  • Chemically modified surfaces for sensor applications.

  • Dry-etched quartz surface topography.

Screenshot_2024-10-30_at_11.48.46-removebg-preview.png
Custom Cell Biology Services
  • Transfection/transduction​

  • Cytotoxicity assays

  • Cell lysate preparation

Screenshot_2024-10-30_at_11.48_edited.png
Aliquot Services
  • Precisely weighed solid reagents to accelerate your workflow

  • Guaranteed weight accuracy within 5%

  • Weighing range of 7 mg to 220 g

bottom of page